ASX Filings

Notice of Annual General Meeting and Proxy Form

September 11, 2020

Appendix 4G and Corporate Governance Statement 2020

September 11, 2020

Annual Report 2020

September 11, 2020

Opthea Appoints US-Based Non-Executive Director

September 10, 2020

Opthea Full Year Financial Report 2020

August 28, 2020

Opthea Announces Plans for Potential US listing and IPO

August 24, 2020

Opthea Completes Successful FDA and EMA Meetings for Phase 3

August 21, 2020

Opthea Key Opinion Leader Symposium Presentation

August 6, 2020

Opthea to Host Wet AMD and DME Key Opinion Leader (KOL) Symposium on August 6, 2020 (AEST)

July 28, 2020

Opthea Reports New Data of OPT-302 in Diabetic Macular Edema at the 2020 Annual Meeting of the American Society of Retina Specialists

July 27, 2020

Additional Formats

PDF Version